WEE1 anticorps (AA 202-230)
Aperçu rapide pour WEE1 anticorps (AA 202-230) (ABIN3029617)
Antigène
Voir toutes WEE1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 202-230
-
Réactivité croisée (Details)
- Expected species reactivity: Rat
-
Purification
- Antigen affinity purified
-
Immunogène
- A portion of amino acids 202-230 from the mouse protein was used as the immunogen for this Wee1 antibody.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Titration of the Wee1 antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the Wee1 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
-
-
- WEE1 (WEE1 Homolog (S. Pombe) (WEE1))
-
Autre désignation
- Wee1
-
Sujet
- Wee1 may act as a negative regulator of entry into mitosis (G2 to M transition) by protecting the nucleus from cytoplasmically activated cyclin B1-complexed CDK1 before the onset of mitosis. Its activity increases during S and G2 phases and decreases at M phase when it is hyperphosphorylated. A correlated decrease in protein level occurs at M/G1 phase, probably due to its degradation. Specifically phosphorylates and inactivates cyclin B1-complexed CDK1 reaching a maximum during G2 phase and a minimum as cells enter M phase. Phosphorylation of cyclin B1-CDK1 occurs exclusively on 'Tyr-15' and phosphorylation of monomeric CDK1 does not occur (By similarity).
-
UniProt
- P47810
-
Pathways
- Cycle Cellulaire, Mitotic G1-G1/S Phases, M Phase
Antigène
-